KRT14 and breast carcinoma: Recently, Pastushenko et al. identified a “partial EMT” state that expresses both vimentin and keratin-14 (but not EpCAM), with increased metastatic potential in mouse models of melanoma (KRasLSL-G12Dp53fl/fl) and breast cancer (MMTV-PyMT) [178].